US Broker Ratings

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Investor Outlook Highlights 25.45% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a leading player in the biotechnology industry, presents a compelling opportunity for investors, boasting a potential upside of 25.45% according to..

Elevance Health, Inc. (ELV) Stock Analysis: A Stable Player with 13.52% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, offers a robust investment case with a compelling potential upside of 13.52%. This..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a Potential Upside of 11.94% Amid Strong Buy Ratings

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $38.46..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking a $402 Billion Giant with Strong Market Position

AbbVie Inc. (ABBV), a major player in the healthcare sector, stands out with a formidable market capitalization of $402.76 billion, making it one of the giants..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating a 16.40% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, commands a market cap of $218.53 billion and holds a prominent position in the..

Astrazeneca PLC (AZN) Stock Analysis: Riding the 11.75% Potential Upside Wave

AstraZeneca PLC (AZN), a towering presence in the biopharmaceutical sector, continues to capture investor attention with its promising growth trajectory and robust pipeline of prescription medicines...

Novo Nordisk A/S (NVO) Investor Outlook: Can This Danish Pharma Giant Deliver a 14% Upside?

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, has been a formidable player in the global pharmaceutical industry for nearly a century. With..

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating the 12% Upside Potential for Investors

Investors in the healthcare sector often look for stable, growth-oriented companies that can withstand market volatility while delivering consistent returns. Becton, Dickinson and Company (NYSE: BDX)..

Gilead Sciences, Inc. (GILD): Investor Outlook with a Solid 2.61% Dividend Yield and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) continues to stand as a formidable player in the biopharmaceutical industry, with a robust market capitalization of $150.06 billion. As a..

Boston Scientific Corporation (BSX) Stock Analysis: Impressive 24.75% Potential Upside Captures Investor Attention

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, offers a compelling narrative for investors seeking robust growth potential. With..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech with a Potential 265% Upside

In the ever-evolving world of biotechnology, MBX Biosciences, Inc. (NASDAQ: MBX) stands out with a compelling case for investors seeking high-growth opportunities. With a market capitalization..

Standard BioTools Inc. (LAB) Stock Analysis: Uncovering a 28.62% Potential Upside in the Healthcare Sector

Standard BioTools Inc. (NASDAQ: LAB), operating within the Healthcare sector, specifically in the Medical Devices industry, is drawing investor attention with its potential for a 28.62%..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: A 94.65% Potential Upside in the Healthcare Sector

Organogenesis Holdings Inc. (NASDAQ: ORGO), a leading player in the regenerative medicine space, is capturing the attention of investors with a tantalizing 94.65% potential upside, according..

Verastem, Inc. (VSTM) Stock Analysis: Nearly 100% Upside Potential Amid Biotech Innovation

Verastem, Inc. (NASDAQ: VSTM), a pioneering biopharmaceutical company, presents a compelling case for investors seeking exposure to the biotechnology sector, particularly in the promising field of..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: 59% Potential Upside Fuels Investor Excitement

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is increasingly capturing the attention of savvy investors, thanks to its remarkable growth potential and promising advancements in the biotechnology sector...

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 106.66% Potential Upside with Solid Buy Ratings

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, particularly in health information services, has captured the attention of investors with its innovative direct-to-patient..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with Strong Revenue Growth

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector specializing in medical care facilities, is navigating a challenging financial landscape. With a market..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a 390% Potential Upside in Biotechnology

Humacyte, Inc. (NASDAQ: HUMA), a pioneering biotechnology company based in Durham, North Carolina, is making waves in the healthcare sector with its cutting-edge approach to engineering..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Biotech Gem with a Potential 215% Upside

As the biotechnology sector continues to captivate investors with its promise of groundbreaking treatments, MeiraGTx Holdings plc (NASDAQ: MGTX) stands out for its ambitious pipeline and..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with 16.91% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds